ArticleFrontiers in oncology2024

Sarcopenia predicts immune-related adverse events due to anti-PD-1/PD-L1 therapy in patients with advanced lung cancer.

Dinglong Xue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.